These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1836142)

  • 1. [Natural suppressors of the human bone marrow tissue].
    Borisov KB
    Biull Eksp Biol Med; 1991 Sep; 112(9):269-71. PubMed ID: 1836142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Normal human bone marrow suppressor cells and in liver cirrhosis].
    Khaitov RM; Gubarev MI; Dzhalalova VA
    Biull Eksp Biol Med; 1985 Dec; 100(12):724-6. PubMed ID: 2934102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural suppressor cells.
    Maier T; Holda JH; Claman HN
    Prog Clin Biol Res; 1989; 288():235-44. PubMed ID: 2524070
    [No Abstract]   [Full Text] [Related]  

  • 4. [Value of hemophagocytosis in the morphological examination of the bone marrow (author's transl)].
    Brugues RM; Vives-Corrons JL; Rozman C; Jou JM; Aguilar JL; Cardellach F; Urbano A; Feliu E
    Med Clin (Barc); 1979 Dec; 73(10):399-402. PubMed ID: 529860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of natural suppression in mediating resistance to antibody-facilitated bone marrow engraftment.
    Sadelain MW; Wegmann TG
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2982-4. PubMed ID: 2523167
    [No Abstract]   [Full Text] [Related]  

  • 6. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of spontaneous and inducible natural killer cell activity in human bone marrow: presence of adherent suppressor cells.
    Uchida A
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):181-92. PubMed ID: 6241292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of B-activin on human T-suppressors].
    Gambarov SS; Khzardzhian AM; Adamian NV; Shakhsuvarov AV; Suzdal'tseva AA
    Biull Eksp Biol Med; 1986 May; 101(5):598-600. PubMed ID: 2939892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone marrow suppressors of MIF production in tumor growth].
    Koval'chuk LV; Sidorovich IG; Gankovskaia LV; Vlasov AA; Sokolova EV
    Dokl Akad Nauk SSSR; 1982; 266(2):497-9. PubMed ID: 6216086
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bone marrow suppressor cells of patients with viral and alcoholic liver cirrhoses].
    Khaitov RM; Dzhalalova VA; Gubarev MI; Pogromov AP; Ivlev AS
    Ter Arkh; 1986; 58(1):82-6. PubMed ID: 3008363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood.
    Mills KC; Gross TG; Varney ML; Heimann DG; Reed EC; Kessinger A; Talmadge JE
    Bone Marrow Transplant; 1996 Jul; 18(1):53-61. PubMed ID: 8831996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoregulatory activity of human bone marrow. Identification of suppressor cells possessing OKM1, SSEA-1, and HNK-1 antigens.
    Mortari F; Bains MA; Singhal SK
    J Immunol; 1986 Aug; 137(4):1133-7. PubMed ID: 2874177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of natural suppressor cells in human bone marrow.
    Sugiura K; Pahwa S; Yamamoto Y; Borisov K; Pahwa R; Nelson RP; Ishikawa J; Iguchi T; Oyaizu N; Good RA; Ikehara S
    Stem Cells; 1998; 16(2):99-106. PubMed ID: 9554033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro suppression of alloreactivity by rhesus monkey bone marrow cells.
    Carver M; Saldanha C; Matthews C; Sash C; Thomas J
    Transplant Proc; 1989 Feb; 21(1 Pt 1):231-2. PubMed ID: 2523128
    [No Abstract]   [Full Text] [Related]  

  • 15. [The activity of nonspecific bone marrow and spleen suppressors in the latent period of tumor growth].
    Ogreba VI; Kusmartsev SA; Vasil'ev NV
    Vopr Onkol; 1988; 34(8):952-5. PubMed ID: 2971291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical studies for adoptive immunotherapy in bone marrow transplantation. Generation of anti-CD3 activated cytotoxic T cells from normal donors and autologous bone marrow transplant candidates.
    Ueda M; Joshi ID; Dan M; Uberti JP; Chou TH; Sensenbrenner LL; Lum LG
    Transplantation; 1993 Aug; 56(2):351-6. PubMed ID: 8356589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mismatched bone marrow transplantation in children with hematologic malignancy using T lymphocyte depleted bone marrow.
    Trigg ME; Sondel PM; Billing R; Finlay JL; Peterson A; Hong R; Frierdich S; Shahidi N
    J Biol Response Mod; 1985 Dec; 4(6):602-12. PubMed ID: 3910764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Suppressor activity of bone marrow and spleen cells in C57Bl/6 mice during carcinogenesis induced by 7,12-dimethylbenz(a)anthracene].
    Kusmartsev SA; Ogreba VI
    Eksp Onkol; 1989; 11(5):23-6. PubMed ID: 2529113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
    Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA
    Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamines as immunomodulators: importance of suppressors and helpers of the bone marrow.
    Devoino L; Idova G; Cheido M; Alperina E; Morozova N
    Methods Find Exp Clin Pharmacol; 1986 Mar; 8(3):175-81. PubMed ID: 2940426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.